UNH Quote, Financials, Valuation and Earnings

The Cigna Group has a net margin of 5.74% compared to UnitedHealth Group's net margin of 2.02%. UnitedHealth Group's return on equity of 21.74% beat The Cigna Group's return on equity of 12.17%.

UnitedHealth Group has a consensus price target of $399.64, signalling upside risk potential of 31.91%. On the other hand The Cigna Group has an analysts' consensus of $375.21 which suggests that it could grow by 20%. Given that UnitedHealth Group has higher upside potential than The Cigna Group, analysts believe UnitedHealth Group is more attractive than The Cigna Group.

UnitedHealth Group has a beta of 0.561, which suggesting that the stock is 43.865% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.472, suggesting its less volatile than the S&P 500 by 52.821%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 2.77%. The Cigna Group offers a yield of 1.83% to investors and pays a quarterly dividend of $1.51 per share. UnitedHealth Group pays 52.29% of its earnings as a dividend. The Cigna Group pays out 45.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $109.6B, which are larger than The Cigna Group quarterly revenues of $65.5B. UnitedHealth Group's net income of $6.3B is higher than The Cigna Group's net income of $1.3B. Notably, UnitedHealth Group's price-to-earnings ratio is 12.69x while The Cigna Group's PE ratio is 17.31x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 0.68x versus 0.34x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.

Centene has a net margin of 5.74% compared to UnitedHealth Group's net margin of 2.81%. UnitedHealth Group's return on equity of 21.74% beat Centene's return on equity of 12.65%.

UnitedHealth Group has a consensus price target of $399.64, signalling upside risk potential of 31.91%. On the other hand Centene has an analysts' consensus of $78.09 which suggests that it could grow by 34.48%. Given that Centene has higher upside potential than UnitedHealth Group, analysts believe Centene is more attractive than UnitedHealth Group.

UnitedHealth Group has a beta of 0.561, which suggesting that the stock is 43.865% less volatile than S&P 500. In comparison Centene has a beta of 0.478, suggesting its less volatile than the S&P 500 by 52.18%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 2.77%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UnitedHealth Group pays 52.29% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $109.6B, which are larger than Centene quarterly revenues of $46.6B. UnitedHealth Group's net income of $6.3B is higher than Centene's net income of $1.3B. Notably, UnitedHealth Group's price-to-earnings ratio is 12.69x while Centene's PE ratio is 8.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 0.68x versus 0.18x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health has a net margin of 5.74% compared to UnitedHealth Group's net margin of 4.47%. UnitedHealth Group's return on equity of 21.74% beat Elevance Health's return on equity of 14.03%.

UnitedHealth Group has a consensus price target of $399.64, signalling upside risk potential of 31.91%. On the other hand Elevance Health has an analysts' consensus of $503.49 which suggests that it could grow by 30.94%. Given that UnitedHealth Group has higher upside potential than Elevance Health, analysts believe UnitedHealth Group is more attractive than Elevance Health.

UnitedHealth Group has a beta of 0.561, which suggesting that the stock is 43.865% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.657, suggesting its less volatile than the S&P 500 by 34.296%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 2.77%. Elevance Health offers a yield of 1.72% to investors and pays a quarterly dividend of $1.71 per share. UnitedHealth Group pays 52.29% of its earnings as a dividend. Elevance Health pays out 25.22% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $109.6B, which are larger than Elevance Health quarterly revenues of $48.9B. UnitedHealth Group's net income of $6.3B is higher than Elevance Health's net income of $2.2B. Notably, UnitedHealth Group's price-to-earnings ratio is 12.69x while Elevance Health's PE ratio is 15.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 0.68x versus 0.49x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare has a net margin of 5.74% compared to UnitedHealth Group's net margin of 2.67%. UnitedHealth Group's return on equity of 21.74% beat Molina Healthcare's return on equity of 25.66%.

UnitedHealth Group has a consensus price target of $399.64, signalling upside risk potential of 31.91%. On the other hand Molina Healthcare has an analysts' consensus of $360.38 which suggests that it could grow by 12.75%. Given that UnitedHealth Group has higher upside potential than Molina Healthcare, analysts believe UnitedHealth Group is more attractive than Molina Healthcare.

UnitedHealth Group has a beta of 0.561, which suggesting that the stock is 43.865% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.702%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 2.77%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UnitedHealth Group pays 52.29% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $109.6B, which are larger than Molina Healthcare quarterly revenues of $11.1B. UnitedHealth Group's net income of $6.3B is higher than Molina Healthcare's net income of $298M. Notably, UnitedHealth Group's price-to-earnings ratio is 12.69x while Molina Healthcare's PE ratio is 15.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 0.68x versus 0.43x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.